Founder variants and population genomes-Toward precision medicine

Adv Genet. 2021:107:121-152. doi: 10.1016/bs.adgen.2020.11.004. Epub 2021 Feb 18.

Abstract

Human migration and community specific cultural practices have contributed to founder events and enrichment of the variants associated with genetic diseases. While many founder events in isolated populations have remained uncharacterized, the application of genomics in clinical settings as well as for population scale studies in the recent years have provided an unprecedented push towards identification of founder variants associated with human health and disease. The discovery and characterization of founder variants could have far reaching implications not only in understanding the history or genealogy of the disease, but also in implementing evidence based policies and genetic testing frameworks. This further enables precise diagnosis and prevention in an attempt towards precision medicine. This review provides an overview of founder variants along with methods and resources cataloging them. We have also discussed the public health implications and examples of prevalent disease associated founder variants in specific populations.

Keywords: Disease; Founder variants; Genetics; Methods; Population genomics; Public health; Resources.

Publication types

  • Review

MeSH terms

  • Databases, Genetic*
  • Finland
  • Founder Effect*
  • Genetic Diseases, Inborn / genetics
  • Genetic Markers
  • Genetics, Population
  • Genome, Human
  • Humans
  • Mutation*
  • Precision Medicine / methods
  • Public Health

Substances

  • Genetic Markers